Nogi, Kazutaka
Kuramitsu, Shoichi https://orcid.org/0000-0001-9927-9686
Hashimoto, Yukihiro
Kawase, Yoshiaki
Shinozaki, Tomohiro
Domei, Takenori
Yamanaka, Futoshi
Kaneko, Umihiko
Kakuta, Tsunekazu
Horie, Kazunori
Terai, Hidenobu
Ando, Hirohiko
Shiono, Yasutsugu
Tagashira, Toru
Kubo, Takashi
Asano, Taku
Shiraishi, Jun
Otake, Hiromasa
Sugano, Akinori
Okabe, Hiroki
Iwai, Atsushi
Kikuta, Yuetsu
Nishina, Hidetaka
Hikoso, Shungo
Amano, Tetsuya
Iwabuchi, Masashi
Yokoi, Hiroyoshi
Akasaka, Takashi
Matsuo, Hitoshi
Tanaka, Nobuhiro
,
Ohashi, Hirofumi
Nakashima, Yuki
Yakuta, Yohei
Yamada, Shinichiro
Toba, Takayoshi
Morofuji, Toru
Ito, Tomoaki
Miyata, Kotaro
Kanaji, Yoshihisa
Naka, Yutaro
Higashioka, Daisuke
Article History
Received: 30 January 2026
Accepted: 7 April 2026
First Online: 6 June 2026
Declarations
:
: Dr. Kuramitsu receives lecture fees from Abbott Medical Japan, Boston Scientific Japan, and Philips Japan. Dr. Kawase receives lecture fees from Abbott Medical Japan, Boston Scientific Japan, Philips Japan, and Zeon Medical; Dr. Ando receives lecture fees from Abbott Medical Japan and Boston Scientific Japan. Dr. Shiono receives lecture fees from Abbott Medical Japan and Philips Japan. Dr. Hikoso receives research funds from Roche diagnostics, Toaeiiyo Ltd. Mochida Pharmaceutical Co., Ltd., and Bristol Myers Squibb. Speakers’ bureau/honorarium from Bristol Myers Squibb, Novartis pharma K.K., Daiichi Sankyo Company, Bayer Yakuhin Ltd. Astellas Pharma, Pfizer Pharmaceuticals, Kowa company, Boehringer Ingelheim Japan Co. Ltd., Ono Pharmaceutical Co. Ltd, Otsuka Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd, Eli Lilly Japan, Sanofi, Nihon Medi-Physics Co., Ltd, Novo Nordisk Pharma Ltd., Mallinckrodt Pharmaceuticals, Nippon Shinyaku Co. Ltd., and Sanwa Kagaku Kenkyuusyo. Dr. Matsuo receives lecture fees from Abbott Medical Japan, Boston Scientific Japan, Philips Japan, and Zeon Medical; Dr. Tanaka receives lecture fees from Abbott Medical Japan and Boston Scientific Japan. The other authors report no conflicts.